Cathie Wood's Ark Investment Management reported significant portfolio activities in Q4 2024, with 193 total stock transactions including selling all Moderna shares. With a net asset value of $12 billion across 183 stocks, technology remains the core focus, comprising around half of the portfolio's value. Despite recent performance challenges, the ARK Innovation ETF (ARKK) showed promising gains at the start of 2025, suggesting a potential recovery. The firm continues to adapt its strategies amid evolving market conditions, indicating strategic investments in genetic stocks for future growth.
Cathie Wood's Ark Investment Management executed 193 moves in Q4 2024, indicating strategic flexibility in a challenging market environment. The firm sold its entire Moderna holdings.
With a total of $12.0 billion in assets across 183 stocks, technology remains a crucial element of Ark's portfolio, balancing growth with market challenges.
Collection
[
|
...
]